Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy
|
Original-Research: H2APEX Group SCA - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research GmbH zu H2APEX Group SCA
First Berlin Equity Research hat ein Research Update zu H2APEX Group SCA (ISIN: LU0472835155) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,70. Zusammenfassung: H2APEX hat H1-Zahlen berichtet, die grob unseren Erwartungen entsprechen. Ein geringeres Projektgeschäft hat zu einem deutlichen Umsatzrückgang geführt; aufgrund niedrigerer Abschreibungen lag der operative Verlust mit €-14,4 Mio. aber nur 8% über dem Vorjahreswert. H2APEX hat ihre Umsatzguidance für 2025 von €6 Mio. - €8 Mio. bestätigt. Die entscheidenden Ereignisse geschahen aber nach dem Halbjahresende: H2APEX hat eine €30 Mio.-Kapitalerhöhung erfolgreich abgeschlossen und danach eine strategische Partnerschaft mit Copenhagen Infrastructure Partners (CIP) zur gemeinsamen Umsetzung eines 100 MW Elektrolyseprojekts in Lubmin vereinbart. Ein aktualisiertes DCF-Modell ergibt ein unverändertes Kursziel von €3,70. Wir bestätigen unsere Kaufempfehlung (Aufwärtspotenzial: 81%). First Berlin Equity Research has published a research update on H2APEX Group SCA (ISIN: LU0472835155). Analyst Dr. Karsten von Blumenthal reiterated his BUY rating and maintained his EUR 3.70 price target. Abstract: H2APEX has reported H1 figures that are broadly in line with our expectations. Lower project business led to a significant decline in revenue; however, due to lower depreciation and amortisation, the operating loss of €14.4m was only 8% higher than in the previous year. H2APEX confirmed 2025 revenue guidance of €6m to €8m. However, two decisive events took place after the end of the half-year period: H2APEX successfully completed its €30m capital increase and subsequently agreed a strategic partnership with Copenhagen Infrastructure Partners (CIP) for the joint implementation of a 100 MW electrolysis project in Lubmin. An updated DCF model yields an unchanged €3.70 price target. We confirm our Buy recommendation (upside: 81%). Bezüglich der Pflichtangaben gem. §85 Abs. 1 S. 1 WpHG und des Haftungsausschlusses siehe die vollständige Analyse. Die vollständige Analyse können Sie hier downloaden: H2A_GR-2025-09-03_DE Kontakt für Rückfragen: Kontakt für Rückfragen First Berlin Equity Research GmbH Herr Gaurav Tiwari Tel.: +49 (0)30 809 39 686 web: www.firstberlin.com E-Mail: g.tiwari@firstberlin.com
Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. |
||||||||||||||||||||
2192332 03.09.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 43,66 | 45,45 | 0,62 | 3,85 | 15,30 | 29,57 | 9,50 | |
| EBITDA1,2 | 6,80 | 7,80 | 2,12 | -9,20 | -16,92 | -16,36 | -21,00 | |
| EBITDA-Margin3 | 15,58 | 17,16 | 341,94 | -238,96 | -110,59 | -55,33 | -221,05 | |
| EBIT1,4 | 3,71 | 4,35 | -1,14 | -10,50 | -22,15 | -25,56 | -25,50 | |
| EBIT-Margin5 | 8,50 | 9,57 | -183,87 | -272,73 | -144,77 | -86,44 | -268,42 | |
| Net Profit (Loss)1 | 2,52 | 3,11 | 87,05 | -12,95 | -24,64 | -27,82 | -30,60 | |
| Net-Margin6 | 5,77 | 6,84 | 14.040,32 | -336,36 | -161,05 | -94,08 | -322,11 | |
| Cashflow1,7 | 5,44 | 7,45 | 4,08 | -15,28 | -14,81 | -18,45 | -21,90 | |
| Earnings per share8 | 0,13 | 0,16 | 4,34 | -0,65 | -0,69 | -0,77 | -0,84 | |
| Dividend per share8 | 1,75 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: BDO
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| H2APEX Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0YF5P | LU0472835155 | SCA | 69,71 Mio € | 27.07.2011 | Kaufen | 9F5JW73M+H5 |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| -3,66 | 16,62 | -0,22 | -4,96 | 4,68 | -3,78 | 2,36 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 27.06.2025 | 28.05.2025 | 28.08.2025 | 24.11.2025 | 12.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -17,19% | -33,83% | -76,61% | -75,28% | -86,90% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
